A prospective study examining the effect of brolcizumab on neovascular age-related macular degeneration in Japanese with treat and extend
Latest Information Update: 03 Jun 2022
At a glance
- Drugs Brolucizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 03 Jun 2022 New trial record